|
1
|
Hu M, Ou-Yang HF, Han XP, Ti XY and Wu CG:
KyoT2 downregulates airway remodeling in asthma. Int J Clin Exp
Pathol. 8:14171–14179. 2015.PubMed/NCBI
|
|
2
|
Robinson DS: Th-2 cytokines in allergic
disease. Br Med Bull. 56:956–968. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pedersen SE, Hurd SS, Lemanske RF Jr,
Becker A, Zar HJ, Sly PD, Soto-Quiroz M, Wong G and Bateman ED:
Global Initiative for Asthma: Global strategy for the diagnosis and
management of asthma in children 5 years and younger. Pediatr
Pulmonol. 46:1–17. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Izuhara K, Ohta S, Shiraishi H, Suzuki S,
Taniguchi K, Toda S, Tanabe T, Yasuo M, Kubo K, Hoshino T, et al:
The mechanism of mucus production in bronchial asthma. Curr Med
Chem. 16:2867–2875. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang HY and Chiang BL: siRNA as a therapy
for asthma. Curr Opin Mol Ther. 11:652–663. 2009.PubMed/NCBI
|
|
6
|
Liu W, Liu S, Verma M, Zafar I, Good JT,
Rollins D, Groshong S, Gorska MM, Martin RJ and Alam R: Mechanism
of TH2/TH17-predominant and neutrophilic
TH2/TH17-low subtypes of asthma. J Allergy
Clin Immunol. 139:1548–1558.e4. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lynch JP, Ferreira MA and Phipps S:
Th2/Th17 reciprocal regulation: Twists and turns in the complexity
of asthma phenotypes. Ann Transl Med. 4 Suppl 1:S592016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gour N and Wills-Karp M: IL-4 and IL-13
signaling in allergic airway disease. Cytokine. 75:68–78. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gandhi NA, Pirozzi G and Graham NMH:
Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert
Rev Clin Immunol. 13:425–437. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomkinson A, Tepper J, Morton M, Bowden A,
Stevens L, Harris P, Lindell D, Fitch N, Gundel R and Getz EB:
Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in
a monkey model of asthma. Allergy. 65:69–77. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Moynihan BJ, Tolloczko B, El Bassam S,
Ferraro P, Michoud MC, Martin JG and Laberge S: IFN-gamma, IL-4 and
IL-13 modulate responsiveness of human airway smooth muscle cells
to IL-13. Respir Res. 9:842008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Blease K: Therapeutics targeting IL-13 for
the treatment of pulmonary inflammation and airway remodeling. Curr
Opin Investig Drugs. 9:1180–1184. 2008.PubMed/NCBI
|
|
13
|
Zhou Z, Zhao Y, Gu L, Niu X and Lu S:
Inhibiting proliferation and migration of lung cancer using small
interfering RNA targeting on Aldo-keto reductase family 1 member
B10. Mol Med Rep. 17:2153–2160. 2018.PubMed/NCBI
|
|
14
|
Qin HB, Xu B, Mei JJ, Li D, Liu JJ, Zhao
DY and Liu F: Inhibition of miRNA-221 suppresses the airway
inflammation in asthma. Inflammation. 35:1595–1599. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li JJ, Tay HL, Maltby S, Xiang Y, Eyers F,
Hatchwell L, Zhou H, Toop HD, Morris JC, Nair P, et al: MicroRNA-9
regulates steroid-resistant airway hyperresponsiveness by reducing
protein phosphatase 2A activity. J Allergy Clin Immunol.
136:462–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dissanayake E and Inoue Y: MicroRNAs in
allergic disease. Curr Allergy Asthma Rep. 16:672016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng MJ, Shi F, Qiu C and Peng WK:
MicroRNA-181a, −146a and −146b in spleen CD4+ T lymphocytes play
proinflammatory roles in a murine model of asthma. Int
Immunopharmacol. 13:347–353. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen N, Wang J, Hu Y, Cui B, Li W, Xu G,
Liu L and Liu S: MicroRNA-410 reduces the expression of vascular
endothelial growth factor and inhibits oxygen-induced retinal
neovascularization. PLoS One. 9:e956652014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jin R, Guo S, Wang MY, Li YH, Wu LX, Ma H,
Lowrie DB, Fan XY and Zhang JH: Administration of mycobacterial
Ag85A and IL-17A fusion protein attenuates airway inflammation in a
murine model of asthma. Int Immunopharmacol. 17:1067–1074. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Lin R, Zhao B, Guan R, Li T and Jin
R: Correlation between oxidative stress and the NF-κB signaling
pathway in the pulmonary tissues of obese asthmatic mice. Mol Med
Rep. 13:1127–1134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang Y, Xue Y, Liu Y, Song G, Lv G, Wang
Y, Wang Y, Li X and Yang L: MicroRNA-146a expression inhibits the
proliferation and promotes the apoptosis of bronchial smooth muscle
cells in asthma by directly targeting the epidermal growth factor
receptor. Exp Ther Med. 12:854–858. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu Y, Yang K, Shi H, Xu J, Zhang D, Wu Y,
Zhou S and Sun X: MiR-21 modulates human airway smooth muscle cell
proliferation and migration in asthma through regulation of PTEN
expression. Exp Lung Res. 41:535–545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ariel D and Upadhyay D: The role and
regulation of microRNAs in asthma. Curr Opin Allergy Clin Immunol.
12:49–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Solberg OD, Ostrin EJ, Love MI, Peng JC,
Bhakta NR, Hou L, Nguyen C, Solon M, Nguyen C, Barczak AJ, et al:
Airway epithelial miRNA expression is altered in asthma. Am J
Respir Crit Care Med. 186:965–974. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou H, Li J, Gao P, Wang Q and Zhang J:
miR-155: A novel target in allergic asthma. Int J Mol Sci. 17(pii):
E17732016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deshpande DA, Dileepan M, Walseth TF,
Subramanian S and Kannan MS: MicroRNA regulation of airway
inflammation and airway smooth muscle function: Relevance to
asthma. Drug Dev Res. 76:286–295. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Al-Quraishy S, Dkhil MA, Delic D,
Abdel-Baki AA and Wunderlich F: Organ-specific
testosterone-insensitive response of miRNA expression of C57BL/6
mice to Plasmodium chabaudi malaria. Parasitol Res.
111:1093–1101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Sun E, Li X, Zhang M, Tang Z, He
L and Lv K: miR-155 contributes to Df1-induced asthma by increasing
the proliferative response of Th cells via CTLA-4 downregulation.
Cell Immunol. 314:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sharma A, Kumar M, Ahmad T, Mabalirajan U,
Aich J, Agrawal A and Ghosh B: Antagonism of mmu-mir-106a
attenuates asthma features in allergic murine model. J Appl
Physiol. 113:459–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nelms K, Keegan AD, Zamorano J, Ryan JJ
and Paul WE: The IL-4 receptor: Signaling mechanisms and biologic
functions. Annu Rev Immunol. 17:701–738. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stirling RG and Chung KF: Future
treatments of allergic diseases and asthma. Br Med Bull.
56:1037–1053. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jia Y, Fang X, Zhu X, Bai C, Zhu L, Jin M,
Wang X, Hu M, Tang R and Chen Z: IL-13+ type 2 innate
lymphoid cells correlate with asthma control status and treatment
response. Am J Respir Cell Mol Biol. 55:675–683. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang L, Oh SY, Wu X, Oh MH, Wu F,
Schroeder JT, Takemoto CM, Zheng T and Zhu Z: SHP-1 deficient mast
cells are hyperresponsive to stimulation and critical in initiating
allergic inflammation in the lung. J Immunol. 184:1180–1190. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Veremeyko T, Siddiqui S, Sotnikov I, Yung
A and Ponomarev ED: IL-4/IL-13-dependent and independent expression
of miR-124 and its contribution to M2 phenotype of monocytic cells
in normal conditions and during allergic inflammation. PLoS One.
8:e817742013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kumar M, Ahmad T, Sharma A, Mabalirajan U,
Kulshreshtha A, Agrawal A and Ghosh B: Let-7 microRNA-mediated
regulation of IL-13 and allergic airway inflammation. J Allergy
Clin Immunol. 128:1077–1085, e1-e10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Z, Chen X, Wu Q, Song J, Wang L and Li
G: miR-125b inhibits goblet cell differentiation in allergic airway
inflammation by targeting SPDEF. Eur J Pharmacol. 782:14–20. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cortes JR, Rivas MD, Molina-Infante J,
Gonzalez-Nuñez MA, Perez-G M, Masa JF, Sanchez JF and Zamorano J:
Omeprazole inhibits IL-4 and IL-13 signaling signal transducer and
activator of transcription 6 activation and reduces lung
inflammation in murine asthma. J Allergy Clin Immunol. 124:607–610,
610.e1. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Karo-Atar D, Bitton A, Benhar I and Munitz
A: Therapeutic targeting of the interleukin-4/interleukin-13
signaling pathway: In allergy and beyond. BioDrugs. May
7–2018.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
